0% found this document useful (0 votes)
57 views17 pages

Understanding Inflammatory Bowel Disease

The document discusses inflammatory bowel disease (IBD), specifically ulcerative colitis and Crohn's disease. It provides details on the differences between the two conditions, including that ulcerative colitis only affects the colon and rectum while Crohn's disease can impact any part of the digestive tract. The literature review covers definitions of IBD, comparisons to irritable bowel syndrome, characteristics of Crohn's disease and ulcerative colitis, and symptoms of ulcerative colitis.
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
57 views17 pages

Understanding Inflammatory Bowel Disease

The document discusses inflammatory bowel disease (IBD), specifically ulcerative colitis and Crohn's disease. It provides details on the differences between the two conditions, including that ulcerative colitis only affects the colon and rectum while Crohn's disease can impact any part of the digestive tract. The literature review covers definitions of IBD, comparisons to irritable bowel syndrome, characteristics of Crohn's disease and ulcerative colitis, and symptoms of ulcerative colitis.
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Assignment on Inflammatory Bowel Disease

A practice school report submitted

In Partial Fulfillment of the Requirements of the Degree of

BACHELOR OF PHARMACY (PRACTICE)


By
Pankaj Yadav
221405001

Under Supervision of

Ms. Chetna Chouhan,


Assistant Professor,
SGT College of Pharmacy, Gurugram

SHREE GURU GOBIND SINGH TRICENTENARY UNIVESITY,


GURUGRAM, HARYANA, INDIA
JUNE 2023
CERTIFICATE

This is certified that the Assignment/ project entitled “Inflammatory


Bowel Disease”, submitted by Pankaj Yadav (221405001) in partial fulfillment of
Practice School, course code- for the Degree of BACHELOR OF
PHARMACY (PRACTICE), session 2022-23 is his work carried out under our
supervision and guidance.

Ms. Chetna Chouhan,


Assistant Professor,
SGT College of Pharmacy,
Gurugram
DECLARATION

I hereby declare that this submission is my own work and that, to the best
of my knowledge and belief, it contains no material which to a substantial extent
has been accepted for the award of any other degree or diploma of the
university or other institution of higher learning, except where due
acknowledgement has been made in the text.

Pankaj Yadav
221405001
B Pharmacy Practice 1st year
SGT College of Pharmacy
SGT University, Gurugram
ACKNOWLEDGEMENT

I would like to express my gratitude and sincere thanks to my mentor Ms.


Chetna Chouhan, Assistant Professor, SGT College of Pharmacy, SGT University,
Gurugram for her support guidance, encouragement and cooperation during my
project work.
I deeply acknowledge the support and valuable guidance rendered to me
from time to again by Prof. (Dr.) Vijay Bhalla, Dean, SGT College of Pharmacy,
SGT University, Gurugram.
I further extend my sincere gratitude to all my teachers and friends for
their kind cooperation and support during my assignment/project work.

Pankaj Yadav
221405001
B Pharmacy Practice 1st year
SGT College of Pharmacy
SGT University, Gurugram
Table of Content:-

Sr. No. Content Page No.

1. Introduction

2. Objective of Study

3. Literature Review

4. Materials and Methods of Diagnosis

5. Results and Discussion

6. Conclusion
Introduction

Inflammatory bowel disease is a chronic inflammatory process of the lining of


gastro-intestinal (GI) tract. If left untreated, it can result in the build-up of scar
tissue, and even potentially to lymphoma. The inflammation usually causes
diarrhoea and abdominal pain, it is classified as an autoimmune disease: i.e.
Body’s own immune system attacks the GI tract
Inflammatory bowel disease is used to describe two different conditions:
Ulcerative colitis and Crohn’s disease.
The GI tract is responsible for digestion of food, absorption of nutrients, and
elimination of waste.
Inflammation impairs the ability of affected GI organs to function properly,
leading to symptoms such as
Persistent diarrhoea, abdominal pain, rectal bleeding, weight loss and fatigue.
While ongoing inflammation
In the GI tract occurs in both Crohn’s disease and Ulcerative colitis, they present
different clinical features.
Inflammatory bowel disease (IBD) is a group of disorders that cause chronic
inflammation (pain and swelling) in the intestines. IBD includes Crohn’s disease
and ulcerative colitis. Both types affect the digestive system. Treatments can
help manage this lifelong condition.
Crohn’s Disease Crohn’s disease can affect any part of the GI tract, from the
mouth to the anus. It most commonly affects the end of the small intestine (the
ileum) where it joins the beginning of the colon.
Crohn’s disease may appear in “patches,” affecting some areas of the GI tract
while leaving other sections completely untouched. In Crohn’s disease, the
inflammation may extend through the entire thickness of the bowel wall.
Ulcerative Colitis Ulcerative colitis is limited to the large intestine (colon) and
the rectum. The inflammation occurs only in the innermost layer of the lining of
the intestine. It usually begins in the rectum and lower colon, but may also
spread continuously to involve the entire colon.
Objective of Study
Both types of IBD can strike at any age but most patients first experience
problems between ages 10 and 30, with a smaller peak incidence between ages
50 and 60. Both diseases have familial tendency: 10% to 20% of patients with
IBD have at least one relative who also has IBD.

Historically, inflammatory bowel disease (IBD) was most common in


North America and Europe and more common with a north-south gradient. Over
the past century, there has been a marked increase in IBD in general and in
childhood IBD in particular and over the past 50 years IBD has spread into the
developing world. The greatest risk factor of developing IBD is an affected family
member. Most patients with IBD do not have an affected family member. IBD is
more common in urban than rural regions and is associated with “good
standards” of domestic hygiene during childhood. People who migrate from
areas with a low incidence to areas with a high incidence of IBD have an
increased risk of developing IBD and the younger they are when they migrate,
the greater their risk of developing IBD. Moreover, people who migrate from
regions with a high incidence to areas with a low incidence of IBD have a
decreased risk of developing IBD. Together, these findings strongly suggest
particular environmental exposures occurring early in life may trigger
inflammatory bowel disease in genetically susceptible individuals. The key is
figuring out what those exposures might be.

Around 25 percent of patients with IBD are diagnosed in the first 2


decades of their life. Of them, most are diagnosed in childhood (about 13-18
years) and its incidence is increasing in the early second decade of life.
Moreover, studies from a variety of countries demonstrate that the incidence of
IBD in increasing, especially in adolescence.
Literature Review

Inflammatory bowel disease (IBD) is a group of disorders that cause


chronic inflammation (pain and swelling) in the intestines. Inflammatory bowel
disease (IBD) is a group of inflammatory conditions of the colon and small
intestine, Crohn's disease and ulcerative colitis (UC) being the principal
types. Crohn's disease affects the small intestine and large intestine, as well as
the mouth, oesophagus, stomach and the anus, whereas ulcerative colitis
primarily affects the colon and the rectum. The term inflammatory bowel
disease (IBD) describes a group of disorders in which the intestines become
inflamed. It has often been thought of as an autoimmune disease, but research
suggests that the chronic inflammation may not be due to the immune system
attacking the body itself. Instead, it is a result of the immune system attacking a
harmless virus, bacteria, or food in the gut, causing inflammation that leads to
bowel injury.

Difference between inflammatory bowel disease (IBD) and irritable bowel


syndrome (IBS)-

IBD is a disease; IBS is a syndrome, or group of symptoms. The causes and


treatments are different.

IBS is a type of functional gastrointestinal disease. It affects how the


bowels function, causing them to contract more (or sometimes less) often than
usual. IBS is also known as spastic colon or nervous stomach.

IBS doesn’t inflame or damage the intestines like IBD, so imaging scans
can’t detect it and it doesn’t increase the risk of colon cancer. People with IBS
rarely need hospitalization or surgery.

Crohn’s disease and ulcerative colitis are the main types of IBD. Types
include:

1. Crohn’s disease causes pain and swelling in the digestive tract. It can
affect any part from the mouth to the anus. It most commonly affects
the small intestine and upper part of the large intestine.

2. Ulcerative colitis causes swelling and sores (ulcers) in the large


intestine (colon and rectum).

1. Ulcerative colitis :
This involves inflammation of the large intestine — but only in the
digestive tract. It can lead to other non-digestive issues. Always involves the
rectum and inflammation can extends continuously throughout the colon to an
extent. It only affects the colon and only affects the mucosa of the gut wall and
is common in young adults15-25 and second peak in 6th decade.
Chronic inflammation results in ulceration with loss of goblet cells and the
formation of abscesses.
Image Ulcerative colitis
Symptoms of Ulcerative colitis:
 Bloody diarrhoea.
 Fever.
 Passage of mucus.
 Episodic cramps.
 Anorexia.
 Nausea.
 Abdominal pain.

2. Crohn’s disease:
This involves Chronic transmural inflammation – i.e. involves all layers of
the gut wall and is Highly heterogeneous and may progress from
inflammation to abdominal abscesses. It is Not region specific i.e. can affect
any region of the GI tract (Small intestine involvement – most cases 80%,
Colitis alone - 15-20%).
It Causes loss of tolerance to intestinal microflora and results in damage to
the gut wall.
It can result in abscesses, strictures, fissures and fistula which can require
surgery.
Symptoms of Crohn’s Disease:
 Colonic involvement.
 Recurrent mild diarrhoea.
 Cramps and fevers lasting for days or weeks.
 Fatigue.
 Small intestine involvement.
Etiology:

The exact cause of IBD is unknown, several factors may be responsible for
the IBD. The following Etiological factors may increase the risk of IBD:
1) Autoimmune Disorder.
2) Genetics.
3) Poor Hygiene.
4) Bacterial and Viral Infections.
5) Environmental Factors like smoking, alcohol drinking, oral
contraceptive etc.

Pathogenesis:

Due to etiological factors

Irritation of cells

Inflammation of cell

Ulceration

Inflammatory Bowel Disease

Common symptoms of IBD: As with other chronic diseases, a person with IBD
will generally go through periods in which the disease flares up and causes
symptoms, followed by periods in which symptoms decrease or disappear and
good health returns. Symptoms range from mild to severe and generally depend
upon what part of the intestinal tract is involved. They include:
 Abdominal cramps and pain
 Diarrhoea that may be bloody
 Severe urgency to have a bowel movement
 Fever
 Weight loss
 Loss of appetite
 Iron deficiency anaemia due to blood loss

Materials and Methods of Diagnosis


The doctor makes the diagnosis of inflammatory bowel disease based on the
patient’s symptoms and various exams and tests:

1. Stool exam: The Patient will be asked for a stool sample that will be sent
to a laboratory to rule out the possibility of bacterial, viral, or parasitic
causes of diarrhea. In addition, the stool will be examined for traces of
blood that cannot be seen with the naked eye.

2. Complete blood count: A nurse or lab technician will draw blood, which
will then be tested in the lab. An increase in the white blood cell count
suggests the presence of inflammation. And if the patient have severe
bleeding, the red blood cell count and hemoglobin level may decrease.

3. Other blood tests: Electrolytes (sodium, potassium), protein, and markers


of inflammation, such as erythrocyte sedimentation rate (ESR) and C-
reactive protein (CRP), may be drawn to look at how serious the disease
is.

4. Other radiologic tests: Computed tomography (CT scan), magnetic


resonance imaging (MRI), and ultrasound have also been used in the
diagnosis of Crohn's disease and ulcerative colitis.

5. Sigmoidoscopy: In this procedure, a doctor uses a sigmoidoscope, a


narrow, flexible tube with a camera and light, to visually examine the last
one-third of your large intestine, which includes the rectum and the
sigmoid colon. The sigmoidoscope is inserted through the anus and the
intestinal wall is visually examined for ulcers, inflammation, and bleeding.
The doctor may also take samples, called biopsies, of the intestinal lining
with an instrument inserted through the tube. These will then be
examined in a laboratory under a microscope.
6. Colonoscopy: A colonoscopy is similar to a sigmoidoscopy, except that the
doctor will use a colonoscope, a longer flexible tube, to examine the entire
colon. This procedure gives you a look at the extent of disease in the
colon.

7. Upper endoscopy. If the patient have upper GI symptoms such as nausea


and vomiting, a doctor will use an endoscope, a narrow, flexible tube with
a camera and light that will be inserted through the mouth -- to examine
oesophagus, stomach, and duodenum, which is the first part of small
intestine. Ulceration occurs in the stomach and duodenum in up to one
out of every 10 people with Crohn's disease.

8. Capsule endoscopy. This test may be helpful to diagnose disease in the


small intestine, such as in Crohn's disease. The Patient swallow a small
capsule that has a camera in it. Pictures are taken of the esophagus,
stomach and small bowel and then sent to a receiver patient wear on a
belt. At the end of the procedure, the pictures are downloaded from the
receiver onto a computer. The camera is passed through body into the
toilet.
Results and Discussion

The doctor will diagnose IBD based on the patient’s signs and symptoms,
medical and family histories, and test results.

IBD complications:
Complications may include:
IBD can lead to several serious complications in the intestines, including:
 Profuse intestinal bleeding from the ulcers.
 Perforation, or rupture of the bowel.
 Narrowing -- called a stricture -- and obstruction of the bowel; found in
Crohn's.
 Fistulae (abnormal passages) and perianal disease, disease in the tissue
around the anus. These conditions are more common in Crohn's than in
ulcerative colitis.
 Toxic megacolon, which is an extreme dilation of the colon that is life-
threatening. This is associated more with ulcerative colitis than Crohn's.
 Malnutrition.
 IBD, particularly ulcerative colitis, also increases the risk of colon cancer.
 IBD can also affect other organs. For example, someone with IBD may
have arthritis, skin conditions, inflammation of the eye, liver and kidney
disorders, or bone loss. Of all the complications outside the intestines,
arthritis is the most common. Joint, eye, and skin complications often
happen together.
Conclusion

Prevention and Non Pharmacological Management:

Although no specific diet has been shown to prevent or treat IBD, dietary
changes may be helpful in managing your symptoms. It's important to talk with
your doctor about ways to modify your diet while making sure you get the
nutrients you need. For instance, depending on your symptoms, the doctor may
suggest that you reduce the amount of fibre or dairy products that you consume.
Also, small, frequent meals may be better tolerated. In general, there is no need
to avoid certain foods unless they cause or worsen your symptoms.

One dietary intervention your doctor may recommend is a low-residue


diet, a very restricted diet that reduces the amount of fiber and other
undigested material that pass through your colon. Doing so can help relieve
symptoms of diarrhea and abdominal pain. If you do go on a low-residue diet,
be sure you understand how long you should stay on the diet because a low-
residue diet doesn't provide all the nutrients you need. Your doctor may
recommend that you take vitamin supplements.

Another important aspect of self-care is to learn how to manage stress,


which may worsen your symptoms. One thing you might want to do is to make
a list of things that causes you stress and then consider which ones you can
eliminate from your daily routine. Also, when you feel stress coming on, it can
help to take several deep breaths and release them slowly. Learning to meditate,
creating time for yourself, and regular exercise are all important tools for
reducing the amount of stress in your life.

Participating in a support group puts you in contact with others who know
exactly the effect IBD has on your day-to-day life because they are going through
the same things you are. They can offer support and tips on how to deal with
symptoms and the effect they have on you.
Treatment of IBD:

Doctors treat symptoms of IBD with a few different medications. Some


are taken by mouth, while others are available as injections.

Medicines, such as

1. Antibiotics.

2. Anti-inflammatory

3. Immune suppressive drugs

4. Corticosteroids

5. Analgesics

6. Anti – Diarrheal Drugs.

Common questions

Powered by AI

The main diagnostic methods for distinguishing between Ulcerative Colitis and Crohn's Disease include endoscopic examinations such as colonoscopy and sigmoidoscopy, imaging studies, and capsule endoscopy. In Ulcerative Colitis, endoscopy shows continuous inflammation starting from the rectum and limited to the colonic mucosa . In Crohn's Disease, endoscopy often reveals a patchy distribution of transmural inflammation that can affect any part of the GI tract, with common findings of strictures, abscesses, and fistulas . Imaging studies like CT or MRI can show characteristic Crohn’s findings such as bowel wall thickening and fistulas . Biopsies may show non-caseating granulomas in Crohn's, which are absent in Ulcerative Colitis . Additionally, Crohn's may present 'skip lesions,' unlike the continuous lesions in Ulcerative Colitis .

The primary types of Inflammatory Bowel Disease are Crohn's disease and Ulcerative Colitis. Crohn's disease can affect any part of the gastrointestinal tract from the mouth to the anus, often with patchy inflammation that penetrates through the entire thickness of the bowel wall. It most commonly affects the small intestine, particularly the ileum, and the beginning of the colon . On the other hand, Ulcerative Colitis is limited to the large intestine and the rectum, affecting only the innermost lining of the bowel wall and usually starts from the rectum and spreads continuously along the colon .

Pharmacological treatments for Inflammatory Bowel Disease are aimed at reducing inflammation and maintaining remission. Anti-inflammatory agents such as aminosalicylates and corticosteroids reduce inflammation through different mechanisms: aminosalicylates inhibit the production of inflammatory mediators, while corticosteroids suppress the immune response globally . Immune suppressive drugs like azathioprine and methotrexate reduce immune system activity, targeting pathways involved in chronic inflammation . Biologics, such as anti-TNF agents, target specific cytokines involved in the inflammatory process. Antibiotics are used to treat or prevent infections that contribute to disease exacerbations . While these treatments can be effective in managing symptoms and inducing remission, they come with potential side effects, including infection risk and organ toxicity. The choice of treatment must be tailored to the disease severity, location, and patient response, underlining the necessity for continuous monitoring and adjustment of the treatment regimen .

Genetic factors play a significant role in the development of Inflammatory Bowel Disease (IBD). Approximately 10-20% of patients have a first-degree relative with IBD, indicating a familial tendency . Research suggests that multiple genetic markers are associated with increased susceptibility, with certain alleles linked to both Crohn's Disease and Ulcerative Colitis . Genome-wide association studies have identified over 160 genetic loci related to IBD, implicating genes involved in immune regulation and barrier function of intestinal epithelial cells . The complex interplay between these genetic factors and environmental exposures early in life is thought to trigger IBD in genetically susceptible individuals. Continued research is focused on identifying specific genetic mechanisms and their interactions with the environment, offering potential targets for personalized treatment approaches .

Smoking has different effects on Crohn's Disease and Ulcerative Colitis. It is a known risk factor for the development and exacerbation of Crohn's Disease, potentially increasing disease activity and frequency of surgery needed due to complications such as strictures and fistulas . Conversely, smoking cessation can exacerbate Ulcerative Colitis, possibly due to the anti-inflammatory effects of nicotine on the colonic mucosa, although smoking is not recommended as a treatment . Hence, smoking influences Crohn’s Disease negatively, requiring more aggressive management, while its cessation can sometimes worsen Ulcerative Colitis, illustrating complex interactions with disease pathophysiology and management strategies .

Non-digestive complications of IBD include arthritis, skin conditions, eye inflammation, liver and kidney disorders, and bone loss . These manifestations can significantly affect patient quality of life and require management beyond standard IBD treatment. The most common non-intestinal complication is arthritis, often presenting alongside joint, eye, and skin issues . These complications may result from systemic inflammation or side effects of medical treatment for IBD, such as corticosteroids. Effective management of these conditions is critical in preventing further deterioration of health and improving overall patient outcomes. Addressing non-digestive symptoms ensures comprehensive care and highlights the systemic impact of what is often perceived as a solely gastrointestinal disorder .

Inflammatory Bowel Disease (IBD) differs from Irritable Bowel Syndrome (IBS) primarily in that IBD involves chronic inflammation and immune system responses targeting certain antigens in the gastrointestinal tract, which can result in tissue damage . IBD is characterized by significant inflammation due to the immune system's attack on the intestines, potentially involving autoimmune mechanisms or responses to microbial antigens . In contrast, IBS is a functional disorder characterized by symptoms without underlying inflammation or visible intestinal damage, and it does not involve immune system attacks like in IBD .

Emerging research into the environmental triggers of Inflammatory Bowel Disease (IBD) is likely to lead to more targeted and effective treatment approaches. As environmental factors, such as diet, microbial exposure, and lifestyle, are increasingly linked to IBD onset and exacerbations, understanding these relationships could facilitate the development of preventive strategies or interventions aimed at minimizing exposure to harmful triggers . Personalized medicine could see advancements through the identification of environmental interactions with specific genetic profiles, allowing for treatments individualized to correct these interactions. Additionally, therapies enhancing gut flora balance or modulating immune responses triggered by environmental factors could become focal points. This knowledge may shift treatment paradigms from reactive to preventive, aiming to reduce disease incidence through lifestyle changes and early interventions in at-risk populations .

Dietary modifications for managing IBD focus on reducing symptoms by avoiding foods that exacerbate inflammation and discomfort. Recommendations often include a low-residue diet, which minimizes the amount of undigested material passing through the colon, thus alleviating diarrhea and abdominal pain . Reducing fiber and dairy intake might also be suggested, as these can sometimes irritate the digestive system in sensitive individuals . Additionally, eating smaller, frequent meals instead of large ones can help digestion. These interventions do not directly prevent or cure IBD but help manage and reduce symptoms, improving the patient’s quality of life . Consulting with a healthcare provider ensures the dietary plan is balanced and attempts to avoid nutritional deficiencies that can occur with extreme dietary restrictions .

The prevalence of Inflammatory Bowel Disease (IBD) is historically higher in North America and Europe with a north-south gradient, but it has been increasing globally, including in the developing world . Demographically, IBD can occur at any age, but it is most frequently diagnosed between ages 10 and 30, with a smaller peak in incidence between ages 50 and 60. Familial tendency is observed, as 10-20% of patients have a relative with IBD, though most do not . Environmental factors, such as urban living and high standards of hygiene, are associated with increased IBD risk, as they may trigger the disease in genetically predisposed individuals. Migration studies indicate that exposure to environments with high IBD incidence from a young age increases the risk, suggesting that environmental factors interact with genetics to influence disease development .

You might also like